Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.
2.

DNA vaccines against chronic lung infections by Pseudomonas aeruginosa.

Staczek J, Gilleland LB, van der Heyde HC, Gilleland HE.

FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):147-53.

3.

Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.

Price BM, Barten Legutki J, Galloway DR, von Specht BU, Gilleland LB, Gilleland HE Jr, Staczek J.

FEMS Immunol Med Microbiol. 2002 Jun 3;33(2):89-99.

4.

Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.

Price BM, Galloway DR, Baker NR, Gilleland LB, Staczek J, Gilleland HE Jr.

Infect Immun. 2001 May;69(5):3510-5.

5.

Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.

Gilleland HE, Gilleland LB, Staczek J, Harty RN, García-Sastre A, Palese P, Brennan FR, Hamilton WD, Bendahmane M, Beachy RN.

FEMS Immunol Med Microbiol. 2000 Apr;27(4):291-7.

6.
7.

A chimaeric plant virus vaccine protects mice against a bacterial infection.

Brennan FR, Gilleland LB, Staczek J, Bendig MM, Hamilton WD, Gilleland HE Jr.

Microbiology. 1999 Aug;145 ( Pt 8):2061-7.

PMID:
10463172
8.

Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.

Brennan FR, Jones TD, Gilleland LB, Bellaby T, Xu F, North PC, Thompson A, Staczek J, Lin T, Johnson JE, Hamilton WD, Gilleland HE Jr.

Microbiology. 1999 Jan;145 ( Pt 1):211-20.

PMID:
10206701
9.

Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.

Mansouri E, Gabelsberger J, Knapp B, Hundt E, Lenz U, Hungerer KD, Gilleland HE Jr, Staczek J, Domdey H, von Specht BU.

Infect Immun. 1999 Mar;67(3):1461-70.

10.
11.

Low-frequency electromagnetic fields alter the replication cycle of MS2 bacteriophage.

Staczek J, Marino AA, Gilleland LB, Pizarro A, Gilleland HE Jr.

Curr Microbiol. 1998 May;36(5):298-301.

PMID:
9541567
12.

Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.

Gilleland HE Jr, Gilleland LB, Staczek J, Harty RN, Garcia-Sastre A, Engelhardt OG, Palese P.

Behring Inst Mitt. 1997 Feb;(98):291-301.

PMID:
9382753
13.

Analysis by flow cytometry of surface-exposed epitopes of outer membrane protein F of Pseudomonas aeruginosa.

Hughes EE, Matthews-Greer JM, Gilleland HE Jr.

Can J Microbiol. 1996 Aug;42(8):859-62.

PMID:
8776855
15.

Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.

Gilleland HE Jr, Hughes EE, Gilleland LB, Matthews-Greer JM, Staczek J.

Curr Microbiol. 1995 Nov;31(5):279-86.

PMID:
7580798
17.

Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa.

Fox CW, Campbell GD Jr, Anderson WM, Zavecz JH, Gilleland LB, Gilleland HE Jr.

Chest. 1994 May;105(5):1545-50.

PMID:
8181349
19.

Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats.

Grisham MB, Ware K, Gilleland HE Jr, Gilleland LB, Abell CL, Yamada T.

Gastroenterology. 1992 Oct;103(4):1260-6.

PMID:
1397883
21.

Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.

Gilleland LB, Gilleland HE, Gibson JA, Champlin FR.

J Med Microbiol. 1989 May;29(1):41-50.

PMID:
2498520
23.

Adaptive alterations in the outer membrane of gram-negative bacteria during human infection.

Gilleland HE Jr.

Can J Microbiol. 1988 Apr;34(4):499-502. Review.

PMID:
3141031
24.

Perspectives on the potential for successful development of outer membrane protein vaccines.

Gilleland HE Jr, Matthews-Greer JM.

Eur J Clin Microbiol. 1987 Jun;6(3):231-3. Review. No abstract available.

PMID:
3305003
26.
27.
28.
30.
31.
32.
33.
34.

Ultrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa.

Gilleland HE Jr, Murray RG.

J Bacteriol. 1976 Jan;125(1):267-81.

35.

Demonstration of cell division by septation in a variety of gram-negative rods.

Gilleland HE Jr, Murray RG.

J Bacteriol. 1975 Feb;121(2):721-5.

38.
39.

Using one dose of doxycycline or penicillin to treat men with gonococcal urethritis.

Jones SR, Gilleland HE Jr.

HSMHA Health Rep. 1971 Sep;86(9):849-54. No abstract available.

40.

Ultrastructure of the cell wall and the mechanism of cellular division of a gram-variable coccus.

Gilleland HE Jr, Roth IL, Eagon RG.

Can J Microbiol. 1971 Mar;17(3):421-4. No abstract available.

PMID:
5551320
41.

Characterization of a protein-lipopolysaccharide complex released from cell walls of Pseudomonas aeruginosa by ethylenediaminetetraacetic acid.

Rogers SW, Gilleland HE Jr, Eagon RG.

Can J Microbiol. 1969 Jul;15(7):743-8. No abstract available.

PMID:
4978710

Supplemental Content

Loading ...
Support Center